Quantcast
Last updated on April 24, 2014 at 5:30 EDT

Latest Breast cancer Stories

2014-04-04 23:31:28

St. Jude Children’s Research Hospital—Washington University Pediatric Cancer Genome Project finds TP53 gene is altered in nearly all osteosarcomas; results help explain how tumors withstand radiation therapy. Memphis, Tenn. (PRWEB) April 03, 2014 The St. Jude Children’s Research Hospital—Washington University Pediatric Cancer Genome Project found mutations in the tumor suppressor gene TP53 in 90 percent of osteosarcomas, suggesting the alteration plays a key role early in...

2014-04-04 23:22:41

Researchers in Italy say their review of studies on the link between selenium and malignancies like bladder cancer turned up too little evidence to support supplementation. Raleigh, NC (PRWEB) April 04, 2014 Italian scientists say patients fighting bladder cancer and other types of cancer are not likely to get any benefit from the metalloid nutritional supplement, selenium. The new meta-analysis has just been posted on the Cancer Monthly website and can be read by clicking here....

2014-04-04 12:27:16

DUBLIN, Apr. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/w9vbt8/global ) has announced the addition of the "Global Mammography Equipment Market 2014-2018" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) The analysts forecast the Global Mammography Equipment market to grow at a CAGR of 9.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence...

2014-04-04 12:27:12

Initiative aims to help women at high risk and their health care providers TORONTO, April 4, 2014 /CNW/ - Today, on behalf of the Honourable Rona Ambrose, Federal Minister of Health, Stella Ambler, Member of Parliament for Mississauga South, announced a new High Risk Breast Cancer Project, funded by the Public Health Agency of Canada, which aims to increase awareness and understanding among women, health care providers and the general public about the factors that place women at high risk...

2014-04-04 12:27:03

SAN DIEGO, April 4, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, announced today that it will present data on the comparison of Cynviloq(TM) and Abraxane(®) (nab-paclitaxel) pharmacokinetics (PK) from animal studies. The PK data will be presented by Dr. Kouros Motamed, Vice President of Clinical Development & Nanomedicine on April 9 from 8:00 AM to...

2014-04-04 12:23:54

These genes could explain why some women with high-risk mutations suffer from cancer while others do not Today we know that women carrying BCRA1 and BCRA2 gene mutations have a 43% to 88% risk of developing from breast cancer before the age of 70. Taking critical decisions such as opting for preventive surgery when the risk bracket is so wide is not easy. Spanish National Cancer Research Centre (CNIO) researchers are conducting a study that will contribute towards giving every woman far...

2014-04-03 12:56:51

Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. "We wanted to evaluate the long-term relationship of fertility medications and breast cancer risk...

2014-04-03 12:29:59

OTTAWA, April 3, 2014 /CNW/ - On behalf of the Honourable Rona Ambrose, Federal Minister of Health, Stella Ambler, Member of Parliament for Mississauga South, will make an announcement related to breast cancer during Breast Fest, a Rethink Breast Cancer Event. Media are invited to the formal remarks, as well as to tour the world-renowned SCAR Project exhibit, a series of 30 large-scale portraits of young women who have experienced breast cancer, or took proactive measures to...

2014-04-03 12:26:50

NEW YORK, April 3, 2014 /PRNewswire/ -- The Web Marketing Association has announced the winners of its 12(th)annual Internet Advertising Competition Awards. Digital communications company Greater Than One, Inc. (GTO) took home three of the top trophies for 2014: Best Pharmaceuticals Online Video, Best Energy Website, and Best Advocacy Online Video. http://photos.prnewswire.com/prnvar/20140403/NY97751LOGO Best Pharmaceuticals Online Video went to the Breast Cancer Awareness video GTO...

2014-04-03 08:30:01

Joins Renowned Academic Scientists Charles Sawyers, Jose Baselga and Ronald Evans SAN DIEGO, April 3, 2014 /PRNewswire/ -- Seragon Pharmaceuticals Inc., a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, today announced the expansion of the company's Clinical and Scientific Advisory Board (CSAB) and the appointment of Debasish Roychowdhury, M.D., who will serve as Seragon's Acting Chief Medical Officer....


Latest Breast cancer Reference Libraries

Clinical Breast Cancer
2012-06-04 20:06:33

Clinical Breast Cancer is a peer-reviewed medical journal established in 2000 and published bimonthly by Elsevier. As of May 2012, the editor-in-chief is George W. Sledge, Jr. The journal publishes original articles describing various aspects of clinical and translational research of breast cancer. It is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer....

Breast Cancer Research and Treatment
2012-05-07 07:48:55

Breast Cancer Research and Treatment is a peer-reviewed scientific journal published by Springer Verlag. It focuses on the treatment of and investigations in breast cancer. The journal is targeted towards a wide audience of clinical researchers, epidemiologists, immunologists, and cell biologists whom are interested in breast cancer. Articles in this journal include: original research, invited reviews, discussions on controversial issues, book reviews, meeting reports, letters to the editors,...

More Articles (2 articles) »